NanoSIRNA

NanosiRNA® COVID-19: specific antiviral treatment Medesis Pharma has a microemulsion

Learn more

NanoManganese

Medesis Pharma is developing a radioprotection drug to treat people irradiated following

Learn more

Transgene

TRANSGENE (Euronext Paris: TNG), a biotechnology company designing and developing

Learn more

Viral diseases

Text currently

Learn more

Alzheimer’s disease

Alzheimer’s disease is the most frequent cause of dementia and one of the most

Learn more

Nuclear radioprotection drug

The objective of the radioprotection program is to develop a radiomitigation drug,

Learn more

AONYS® drug delivery technology

AONYS® is a mix of lipidic components that spontaneously assemble into a water-in-oil

Learn more

Drug to treat neurodegenerative diseases

NanoLithium® (NP03) is a disease-modifying nano dose formulation of lithium citrate

Learn more

Cesium decorporation

Directly linked to 137Cs are numerous diseases not only limited to the increased

Learn more

We develop new drugs to preserve life

Medesis is a clinical development stage biopharmaceutical company that is engaged

Learn more